Other
Dec 2022Commercialization depends on FDA clearance for broader hospital/lab sales; public filings describe pre-commercial, research-use-only sales and regulatory execution risk.
SourceBlood testing device for early diagnosis of cancer and treatment…
Company research
Public company, workplace, funding, and market signals
Overview
Delee is a medtech/biotech startup focused on liquid-biopsy cancer diagnostics and treatment monitoring through circulating tumor cell (CTC) isolation and analysis.
Primary product
CytoCatch™ Isolation Platform and Imaging System
Founded
2017
Headquarters
1211 San Dario Avenue, Laredo, TX 78040, United States
Team size
11
Industry
Biotechnology Research
Sub-industry
Medical devices / cancer diagnostics
Offices
Laredo, Texas, United States
Open Positions
0 jobs at Delee
No open positions
Check back later for new openings